Pulse Biosciences, Inc. Share Price
Equities
PLSE
US74587B1017
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.32 USD | +1.81% | +7.30% | -39.95% |
01/04 | Sector Update: Health Care Stocks Slide Late Afternoon | MT |
01/04 | Pulse Biosciences Shares Fall After Q4 Results, Rights Issue Plans | MT |
Sales 2021 | 1.42 118.27 | Sales 2022 | 0.7 58.38 | Capitalization | 103M 8.6B |
---|---|---|---|---|---|
Net income 2021 | -63M -5.25B | Net income 2022 | -58M -4.84B | EV / Sales 2021 | 29,72,32,229 x |
Net cash position 2021 | 17.36M 1.45B | Net Debt 2022 | 14.82M 1.24B | EV / Sales 2022 | 16,84,85,877 x |
P/E ratio 2021 |
-6.51
x | P/E ratio 2022 |
-1.61
x | Employees | 61 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 29.62% |
Latest transcript on Pulse Biosciences, Inc.
1 day | +0.83% | ||
1 week | +7.30% | ||
Current month | -15.61% | ||
1 month | -8.01% | ||
3 months | -20.80% | ||
6 months | +66.67% | ||
Current year | -39.95% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Danahy
CEO | Chief Executive Officer | 54 | 14/22/14 |
Chief Tech/Sci/R&D Officer | - | 03/23/03 | |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CHM | Chairman | 79 | 02/17/02 |
Director/Board Member | 46 | 02/17/02 | |
Darrin Uecker
CTO | Chief Tech/Sci/R&D Officer | 59 | 15/15/15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.36% | 4 M€ | -5.15% | - | |
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 7.35 | +2.23% | 83 520 |
26/24/26 | 7.19 | +7.47% | 71,325 |
25/24/25 | 6.69 | -2.48% | 117,307 |
24/24/24 | 6.86 | 0.00% | 129,156 |
23/24/23 | 6.86 | +0.15% | 124,448 |
Delayed Quote Nasdaq, April 29, 2024 at 09:27 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-39.95% | 397M | |
+9.07% | 219B | |
+7.47% | 183B | |
+11.18% | 133B | |
+25.22% | 108B | |
+0.27% | 63.06B | |
+12.33% | 52.02B | |
-0.62% | 48.2B | |
+0.21% | 40.37B | |
+13.14% | 39.35B |
- Stock Market
- Equities
- PLSE Stock